Pre-erythrocytic Activity of M5717 in Monotherapy and Combination in Preclinical <i>Plasmodium</i> Infection Models-Reference-Cited by-同舟云学术

Pre-erythrocytic Activity of M5717 in Monotherapy and Combination in Preclinical Plasmodium Infection Models

Published:2022-03-21 Issue:4 Volume:8 Page:721-727
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Fontinha Diana¹,Arez Francisca²³,Gal Isabella Ramella²³,Nogueira Gonçalo¹,Moita Diana¹,Baeurle Tobias Hyun Ho⁴,Brito Catarina²³,Spangenberg Thomas⁵^ORCID,Alves Paula M.²³^ORCID,Prudêncio Miguel¹^ORCID

Affiliation:

1. Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal

2. iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901 Oeiras, Portugal

3. Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal

4. Site Management − Analytics, the healthcare business of Merck KGaA, 64293 Darmstadt, Germany

5. Global Health Institute of Merck, Ares Trading S.A. (a subsidiary of Merck KGaA Darmstadt Germany), 1262 Eysins, Switzerland

Funder

Merck KGaA

Funda??o para a Ci?ncia e a Tecnologia

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.1c00640

Reference24 articles.

1. WHO. World Malaria Report 2021; World Health Organization: Geneva, Switzerland; 2021.

2. Malaria parasite pre-erythrocytic infection: preparation meets opportunity

3. The silent path to thousands of merozoites: the Plasmodium liver stage

4. Malaria

5. Biology of Malaria Transmission

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the next generation of severe malaria treatment: a target product profile;Malaria Journal;2024-06-05

2. To quest new targets of Plasmodium parasite and their potential inhibitors to combat antimalarial drug resistance;Journal of Parasitic Diseases;2024-05-31

3. Antimalarial Drug Discovery from Natural and Synthetic Sources;Current Medicinal Chemistry;2024-05-30

4. Genetic complexity alters drug susceptibility of asexual and gametocyte stages of Plasmodium falciparum to antimalarial candidates;Antimicrobial Agents and Chemotherapy;2024-03-06

5. Semi-mechanistic population pharmacokinetic/pharmacodynamic modeling of a Plasmodium elongation factor 2 inhibitor cabamiquine for prevention and cure of malaria;Antimicrobial Agents and Chemotherapy;2023-12-14